IP Library Granted Patent US 12,697,210
Granted Patent B2
US 12,697,210 · App. 17/909,608 · Granted Aug 4, 2026

Transcatheter tissue cutting system

Inventor: Ryan S. Titone (Flagstaff, AZ)
Assignee: EDWARDS LIFESCIENCES CORPORATION
A61F2/2427A61B18/149A61B18/1492A61F2/2418A61B2018/00101A61B2018/00369A61B2018/00601A61B2018/1407A61B2018/1475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,697,210
App. No.
17/909,608
Filed
Sep 6, 2022
Granted
Aug 4, 2026
Kind
B2
Art Unit
3794
USPC
606/41
Abstract

Systems and methods for cutting tissue using a transcatheter approach are disclosed. In some examples, the systems and methods are implemented as part of a delivery system that includes an implant with a support structure and a cutting element coupled to the support structure, such that the cutting element configured to cut tissue.

Claims (32)

1 . A delivery system comprising:

a delivery device;

an implant having a support structure, the implant being releasably coupled to the delivery device; and

a tissue cutting system coupled to the delivery device and the implant, the tissue cutting system including a cutting element comprising a wire formed of a conductive material electrically connected to a current source and configured to cut tissue, wherein the wire comprises a first portion and a second portion extending from the first portion,

wherein the first portion of the wire extends through a lumen of the delivery device and the implant and outwardly from a distal tip portion of the delivery device in a distal direction, and

wherein the second portion of the wire extends from a distal end of the first portion of the wire in a proximal direction alongside the delivery device and the implant and then back into the delivery device at a location proximal the distal tip portion of the delivery device.

2 . The delivery system of claim 1 , wherein the first and second portions of the wire form a loop portion that extends radially outward relative to the delivery device, and wherein the loop portion is configured to be adjusted in size by a user.

3 . The delivery system of claim 1 , wherein the cutting element comprises a protective cover extending partially over the wire and rendering at least a portion of the wire inoperable for cutting tissue.

4 . The delivery system of claim 1 , further comprising an outer sheath retractably disposed over at least a portion of the cutting element.

5 . The delivery system of claim 4 , wherein the outer sheath comprises a thermally insulating material.

6 . The delivery system of claim 4 , wherein the outer sheath comprises an electrically insulating material.

7 . The delivery system of claim 4 , wherein the outer sheath comprises an abrasion-resistant material.

8 . The delivery system of claim 1 , wherein the support structure comprises a leaflet frame subcomponent and an anchor frame subcomponent.

9 . The delivery system of claim 8 , wherein the support structure further comprises an interstage flexibly coupling the leaflet frame subcomponent and the anchor frame subcomponent.

10 . The delivery system of claim 9 , wherein the cutting element is coupled to the interstage.

11 . The delivery system of claim 8 , wherein the cutting element extends through a framework of the leaflet frame subcomponent or the anchor frame subcomponent.

12 . The delivery system of claim 1 , wherein the support structure is configured to be self-expanding.

13 . The delivery system of claim 1 , wherein the support structure is configured to assume a collapsed, delivery configuration and an expanded, deployed configuration.

14 . The delivery system of claim 1 , wherein the cutting element is configured to cut tissue when the implant is in a deployed configuration.

15 . The delivery system of claim 14 , wherein the cutting element is configured to be uncoupled from the delivery system or the implant.

16 . The delivery system of claim 1 , wherein the delivery device comprises shaft defining the lumen through which the first portion of the wire extends, wherein the implant is mounted around the shaft such that the first portion and the second portion of the wire form a loop that extends through and alongside the implant.

17 . A method of delivering an implant to a treatment site, the method comprising:

positioning the implant at the treatment site with a delivery device; and

cutting tissue at the treatment site with a cutting element that is coupled to the delivery device and the implant, wherein the cutting element comprises a first portion and a second portion extending from the first portion,

wherein the first portion of the cutting element extends through a lumen of the delivery device and the implant and then distally from an opening in a distal tip portion of the delivery device, and

wherein the second portion of the cutting element curves from a distal end of the first portion of the cutting element in a proximal direction alongside the delivery device and the implant and back into the delivery device.

18 . The method of claim 17 , wherein the first and second portions of the cutting element define a loop portion, and wherein the method further comprises adjusting a size of the loop portion prior to cutting the tissue.

19 . The method of claim 17 , further comprising:

uncoupling the cutting element from the implant after the tissue is cut, and removing the cutting element from the treatment site.

20 . The method of claim 17 , further comprising:

deploying the implant at the treatment site, wherein the tissue is cut at least one of prior to, during, or following deploying the implant.

21 . A method for treating a human patient with a diagnosed condition or disease associated with valve insufficiency or valve failure of a native valve, the method comprising implanting the implant of claim 1 , the implant being a prosthetic valve, the prosthetic valve being implanted at or adjacent to a location associated with the native valve.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2023
From: W.L. GORE & ASSOCIATES, INC.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 065021/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2023
From: TITONE, RYAN S.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 062652/0591 →
Continuity (2)
Provisional Application 62984554 · Mar 3, 2020
Related Publication 20230105063A1 · Apr 6, 2023
References Cited (172)
US 3574865A · Hamaker et al. · 1971 [cited by applicant]
US 4493321A · Leather · 1985 [cited by applicant]
US 4765332A · Fischell et al. · 1988 [cited by applicant]
US 5026383A · Nobles · 1991 [cited by applicant]
US 5069679A · Taheri · 1991 [cited by applicant]
US 5078716A · Doll · 1992 [cited by examiner]
US 5108370A · Walinsky · 1992 [cited by applicant]
US 5232446A · Arney · 1993 [cited by applicant]
US 5304134A · Kraus et al. · 1994 [cited by applicant]
US 5470313A · Crocker et al. · 1995 [cited by applicant]
US 5514151A · Fogarty et al. · 1996 [cited by applicant]
US 5593405A · Osypka · 1997 [cited by examiner]
US 5620415A · Lucey et al. · 1997 [cited by applicant]
US 5658302A · Wicherski et al. · 1997 [cited by applicant]
US 5853408A · Muni · 1998 [cited by applicant]
US 5951576A · Wakabayashi · 1999 [cited by applicant]
US 5964778A · Fugoso et al. · 1999 [cited by applicant]
US 5989287A · Yang et al. · 1999 [cited by applicant]
US 6027510A · Alt · 2000 [cited by applicant]
US 6063082A · DeVore et al. · 2000 [cited by applicant]
US 6106530A · Harada · 2000 [cited by applicant]
US 6245040B1 · Inderbitzen et al. · 2001 [cited by applicant]
US 6264683B1 · Stack et al. · 2001 [cited by applicant]
US 6270465B1 · Keith et al. · 2001 [cited by applicant]
US 6450948B1 · Matsuura et al. · 2002 [cited by applicant]
US 6616661B2 · Wellman et al. · 2003 [cited by applicant]
US 6746463B1 · Schwartz · 2004 [cited by applicant]
US 6872215B2 · Crocker et al. · 2005 [cited by applicant]
US 6939359B2 · Tu et al. · 2005 [cited by applicant]
US 6942681B2 · Johnson · 2005 [cited by applicant]
US 7331972B1 · Cox · 2008 [cited by applicant]
US 7341555B2 · Ootawara et al. · 2008 [cited by applicant]
US 8221349B2 · Auyoung et al. · 2012 [cited by applicant]
US 8486097B2 · Mark et al. · 2013 [cited by applicant]
US 8491613B2 · Bliss et al. · 2013 [cited by applicant]
US 8491614B2 · Lemaitre et al. · 2013 [cited by applicant]
US 8556921B2 · Bliss et al. · 2013 [cited by applicant]
US 8979925B2 · Chang et al. · 2015 [cited by applicant]
US 9107666B2 · Manwaring et al. · 2015 [cited by applicant]
US 9119716B2 · Lee et al. · 2015 [cited by applicant]
US 9402986B2 · Bell et al. · 2016 [cited by applicant]
US 10441416B2 · Oba et al. · 2019 [cited by applicant]
US 11648337B2 · Wang et al. · 2023 [cited by applicant]
US 20020082614A1 · Logan et al. · 2002 [cited by applicant]
US 20030114794A1 · Duchamp · 2003 [cited by applicant]
US 20030208195A1 · Thompson · 2003 [cited by examiner]
US 20040073165A1 · Musbach et al. · 2004 [cited by applicant]
US 20040243211A1 · Colliou et al. · 2004 [cited by applicant]
US 20040267280A1 · Nishide et al. · 2004 [cited by applicant]
US 20050137690A1 · Salahieh et al. · 2005 [cited by applicant]
US 20050137700A1 · Spence et al. · 2005 [cited by applicant]
US 20060009832A1 · Fisher · 2006 [cited by applicant]
US 20060074485A1 · Realyvasquez · 2006 [cited by applicant]
US 20060095025A1 · Levine et al. · 2006 [cited by applicant]
US 20060111704A1 · Brenneman et al. · 2006 [cited by applicant]
US 20060259137A1 · Artof et al. · 2006 [cited by applicant]
US 20060271081A1 · Realyvasquez · 2006 [cited by applicant]
US 20070213663A1 · Wang · 2007 [cited by applicant]
US 20080045937A1 · Whisenant et al. · 2008 [cited by applicant]
US 20080125860A1 · Webler et al. · 2008 [cited by applicant]
US 20090012557A1 · Osypka · 2009 [cited by applicant]
US 20090030503A1 · Ho · 2009 [cited by examiner]
US 20090209955A1 · Forster et al. · 2009 [cited by applicant]
US 20100105981A1 · Ho et al. · 2010 [cited by applicant]
US 20100198040A1 · Friedman · 2010 [cited by examiner]
US 20100204662A1 · Orlov et al. · 2010 [cited by applicant]
US 20110004157A1 · Dewaele et al. · 2011 [cited by applicant]
US 20110190867A1 · Vonderwalde et al. · 2011 [cited by applicant]
US 20110218620A1 · Meiri et al. · 2011 [cited by applicant]
US 20110264179A1 · Eckerdal · 2011 [cited by applicant]
US 20110283514A1 · Fogarty et al. · 2011 [cited by applicant]
US 20120083809A1 · Drasler et al. · 2012 [cited by applicant]
US 20120130173A1 · Lutze et al. · 2012 [cited by applicant]
US 20120136385A1 · Cully · 2012 [cited by applicant]
US 20120209377A1 · Machold et al. · 2012 [cited by applicant]
US 20120234893A1 · Schuckmann et al. · 2012 [cited by applicant]
US 20120239142A1 · Liu et al. · 2012 [cited by applicant]
US 20120265156A1 · Devereux et al. · 2012 [cited by applicant]
US 20120289987A1 · Wilson et al. · 2012 [cited by applicant]
US 20130096606A1 · Bruchman et al. · 2013 [cited by applicant]
US 20130116715A1 · Weber · 2013 [cited by applicant]
US 20130289607A1 · Pedersen et al. · 2013 [cited by applicant]
US 20130304036A1 · Kimmel et al. · 2013 [cited by applicant]
US 20130310833A1 · Brown et al. · 2013 [cited by applicant]
US 20140012252A1 · Bliss et al. · 2014 [cited by applicant]
US 20140172003A1 · Goepfrich · 2014 [cited by applicant]
US 20140276764A1 · Shuman · 2014 [cited by examiner]
US 20140296969A1 · Tegels et al. · 2014 [cited by applicant]
US 20140330366A1 · Dehdashtian et al. · 2014 [cited by applicant]
US 20140343660A1 · Shimoyama · 2014 [cited by applicant]
US 20150148896A1 · Karapetian et al. · 2015 [cited by applicant]
US 20150151080A1 · Verbeek · 2015 [cited by applicant]
US 20150202410A1 · Odeh · 2015 [cited by applicant]
US 20150230919A1 · Chau et al. · 2015 [cited by applicant]
US 20150257883A1 · Basude et al. · 2015 [cited by applicant]
US 20150351903A1 · Morriss et al. · 2015 [cited by applicant]
US 20160166243A1 · Wilson et al. · 2016 [cited by applicant]
US 20160206424A1 · Al-Jilaihawi et al. · 2016 [cited by applicant]
US 20160235525A1 · Rothstein · 2016 [cited by examiner]
US 20160270778A1 · Zergiebel · 2016 [cited by applicant]
US 20160346084A1 · Taylor et al. · 2016 [cited by applicant]
US 20170056068A1 · Hess et al. · 2017 [cited by applicant]
US 20170165060A1 · Barongan · 2017 [cited by applicant]
US 20170319333A1 · Tegels et al. · 2017 [cited by applicant]
US 20170361073A1 · Stapleton · 2017 [cited by applicant]
US 20180000509A1 · Wilson et al. · 2018 [cited by applicant]
US 20180008268A1 · Khairkhahan · 2018 [cited by applicant]
US 20180092677A1 · Peterson et al. · 2018 [cited by applicant]
US 20180185153A1 · Bishop et al. · 2018 [cited by applicant]
US 20180214267A1 · Lally et al. · 2018 [cited by applicant]
US 20180214270A1 · Subramanian et al. · 2018 [cited by applicant]
US 20190110893A1 · Haarer et al. · 2019 [cited by applicant]
US 20190255285A1 · Freeseman et al. · 2019 [cited by applicant]
US 20190298517A1 · Sanchez et al. · 2019 [cited by applicant]
US 20190328420A1 · Khairkhahan et al. · 2019 [cited by applicant]
US 20190344054A1 · Slattery et al. · 2019 [cited by applicant]
US 20200038030A1 · Baril et al. · 2020 [cited by applicant]
US 20200146690A1 · Rothstein et al. · 2020 [cited by applicant]
US 20200289102A1 · Wilson et al. · 2020 [cited by applicant]
US 20200297490A1 · Zhou et al. · 2020 [cited by applicant]
US 20200337726A1 · Wilson et al. · 2020 [cited by applicant]
US 20210046291A1 · Sardesai et al. · 2021 [cited by applicant]
US 20210085456A1 · Skarsgard · 2021 [cited by applicant]
US 20210298899A1 · Huddleston · 2021 [cited by applicant]
US 20210346089A1 · Childs et al. · 2021 [cited by applicant]
US 20210378648A1 · Thissen et al. · 2021 [cited by applicant]
US 20210393334A1 · Wilson et al. · 2021 [cited by applicant]
US 20220079738A1 · Schaefer et al. · 2022 [cited by applicant]
US 20220087715A1 · Van Bladel et al. · 2022 [cited by applicant]
US 20220168036A1 · Wei · 2022 [cited by applicant]
US 20220183714A1 · Podmore et al. · 2022 [cited by applicant]
US 20220323148A1 · Rothstein et al. · 2022 [cited by applicant]
US 20230077068A1 · Tamir et al. · 2023 [cited by applicant]
US 20230129792A1 · Hartman et al. · 2023 [cited by applicant]
US 20230233349A1 · Desai et al. · 2023 [cited by applicant]
US 20230248343A1 · Muse et al. · 2023 [cited by applicant]
CN 102834072A · 2012 [cited by applicant]
CN 109700508A · 2019 [cited by applicant]
CN 115024797A · 2022 [cited by applicant]
EP 1132059B1 · 2005 [cited by applicant]
EP 3542763A1 · 2019 [cited by applicant]
FR 2903292A1 · 2008 [cited by applicant]
JP 2008538937A · 2008 [cited by applicant]
JP 2014534874A · 2014 [cited by applicant]
JP 2019503232A · 2019 [cited by applicant]
NL 1008178C2 · 1999 [cited by applicant]
WO WO2006057920A2 · 2006 [cited by applicant]
WO WO2008005405A2 · 2008 [cited by applicant]
WO WO2009155561A2 · 2009 [cited by applicant]
WO WO2012071095A1 · 2012 [cited by applicant]
WO WO2014114798A1 · 2014 [cited by applicant]
WO WO2017074719A1 · 2017 [cited by applicant]
WO 2019089135A1 · 2019 [cited by applicant]
WO WO2019183372A1 · 2019 [cited by examiner]
WO WO2020022842A1 · 2020 [cited by applicant]
WO WO2020053830A1 · 2020 [cited by applicant]
WO WO2021092576A1 · 2021 [cited by applicant]
WO WO2022066097A1 · 2022 [cited by applicant]
WO WO2022066631A1 · 2022 [cited by applicant]
WO WO2022154959A1 · 2022 [cited by applicant]
WO WO2022197680A1 · 2022 [cited by applicant]
WO WO2022231726A1 · 2022 [cited by applicant]
WO WO2023076667A1 · 2023 [cited by applicant]
WO WO2023139576A1 · 2023 [cited by applicant]
WO WO2024006230A1 · 2024 [cited by applicant]
WO WO2024191984A1 · 2024 [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/20438, mailed on Jun. 7, 2021, 14 pages. [cited by applicant]
Babaliaros. Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement: First-in-Human Experience. JACC Cardiovasc Interv. Apr. 24, 20… [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/18383, mailed on May 20, 2021, 14 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/20446, mailed on Jun. 18, 2021, 16 pages. [cited by applicant]
Kasel. International Lampoon: first European experience with laceration of the anterior mitral valve leaflet prior to transseptal transcatheter mitral valve implantation. EuroIntervention. Sep. 20, 2018; 14(7): 746-749.… [cited by applicant]
Khan. Intentional Laceration of the Anterior Mitral Valve Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement: Pre-Clinical Findings. JACC Cardiovasc Interv. Sep. … [cited by applicant]